Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Molly B Schmid

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochemical Pharmacology|February 7, 2006
Crystallizing new approaches for antimicrobial drug discoveryMolly B Schmid
Expert Opinion on Therapeutic Targets|January 24, 2003
Microbial genomics - new targets, new drugsMolly B Schmid
Nature Biotechnology|April 8, 2006
Do targets limit antibiotic discovery?Molly B Schmid
Trends in Microbiology|October 16, 2002
Structural proteomics: the potential of high-throughput structure determinationMolly B Schmid
Nature Reviews. Microbiology|September 17, 2004
Seeing is believing: the impact of structural genomics on antimicrobial drug discoveryMolly B Schmid
Antimicrobial Agents and Chemotherapy|March 30, 2004
Reduced triclosan susceptibility in methicillin-resistant Staphylococcus epidermidisMolly B Schmid, Nachum Kaplan
Nucleic Acids Research|August 18, 2016
The interplay between chromosome stability and cell cycle control explored through gene-gene interaction and computational simulationJesse P Frumkin, Biranchi N Patra, Anthony Sevold, et al.
Journal of Bacteriology|December 4, 2004
Large-scale identification of genes required for full virulence of Staphylococcus aureusBret M Benton, J P Zhang, Skip Bond, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitorNachum Kaplan, Monique Albert, Donald Awrey, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochemical Pharmacology|February 7, 2006
Crystallizing new approaches for antimicrobial drug discoveryMolly B Schmid
Expert Opinion on Therapeutic Targets|January 24, 2003
Microbial genomics - new targets, new drugsMolly B Schmid
Nature Biotechnology|April 8, 2006
Do targets limit antibiotic discovery?Molly B Schmid
Trends in Microbiology|October 16, 2002
Structural proteomics: the potential of high-throughput structure determinationMolly B Schmid
Nature Reviews. Microbiology|September 17, 2004
Seeing is believing: the impact of structural genomics on antimicrobial drug discoveryMolly B Schmid
Antimicrobial Agents and Chemotherapy|March 30, 2004
Reduced triclosan susceptibility in methicillin-resistant Staphylococcus epidermidisMolly B Schmid, Nachum Kaplan
Nucleic Acids Research|August 18, 2016
The interplay between chromosome stability and cell cycle control explored through gene-gene interaction and computational simulationJesse P Frumkin, Biranchi N Patra, Anthony Sevold, et al.
Journal of Bacteriology|December 4, 2004
Large-scale identification of genes required for full virulence of Staphylococcus aureusBret M Benton, J P Zhang, Skip Bond, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitorNachum Kaplan, Monique Albert, Donald Awrey, et al.
Pageof 1